InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Egeland Ryan, Directeur Médical. Director active across 1 company, notably Cardiovascular Systems Inc. Aggregated, 8 filings have been recorded. Activity tracked since 9 August 2021. The latest transaction was disclosed on 8 February 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations8 total
5,477 shares0Common StockSEC:0001437749-22-002882:0
5,477 shares0Common StockSEC:0001437749-22-002882
1,107 shares0Common StockSEC:0000914190-21-000292:0
1,107 shares0Common StockSEC:0000914190-21-000292
1,820 shares@ US$36.0750.0% of flowCommon StockSEC:0000914190-21-000277:0
1,820 shares@ US$36.0750.0% of flowCommon StockSEC:0000914190-21-000277
4,438 shares0Common StockSEC:0000914190-21-000240:0
4,438 shares0Common StockSEC:0000914190-21-000240
8 of 8 declarations
About Egeland Ryan
Ryan Egeland is the Chief Medical Officer at Cardiovascular Systems Inc. He is responsible for the medical direction and innovation in the development of medical devices for the treatment of cardiovascular diseases. Ryan brings valuable clinical expertise to guide the company's research and development initiatives.
